United States· US:47335-410_c67d3234-28c7-40a9-a472-87747bb4242a
Sumatriptan and Naproxen Sodium
A sumatriptan and naproxen product containing sumatriptan succinate; naproxen sodium, registered in United States by Sun Pharmaceutical Industries, Inc.. The same ATC class is registered in 8 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Sumatriptan and naproxen is registered in 8 of 19 countries.
Countries holding a registration under ATC N02CC51 (sumatriptan and naproxen), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Sumatriptan and naproxen · ATC N02CC51
8 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Country
- United States (US)
- ATC code
- N02CC51
- ATC class
- Sumatriptan and naproxen
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1147335-410-22
- ndc1147335-410-83
- ndc1147335-410-88
- ndc1147335410229 TABLET, FILM COATED in 1 BOTTLE (47335-410-22)
- ndc11473354108330 TABLET, FILM COATED in 1 BOTTLE (47335-410-83)
- ndc114733541088100 TABLET, FILM COATED in 1 BOTTLE (47335-410-88)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sumatriptan and naproxen in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFRIMIG DUOOrion Corporation, Espoo
- PolandFrimig DuoOrion Corporation
- SpainSUVEXX 85 MG/500 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULAOrion Corporation
- FinlandNomigrinOrion Corporation
- FranceNOMANESIT 85 mg/500 mg comprimé pelliculéORION CORPORATION
- CanadaSUVEXXARALEZ PHARMACEUTICALS CANADA INC
- IrelandMigsun 85 mg/500 mg film-coated tabletsOrion Corporation
- NetherlandsSuvexx 85 mg/500 mg filmomhulde tablettenOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Sumanet
- Belgium · Migsun
- Czechia · Frimig Duo
- Germany · Suvexx
- Denmark · Nomigrin
- Estonia · Migsun
- Spain · Suvexx
- Finland · Nomigrin
- France · Nomanesit
- United Kingdom (Northern Ireland) · Suvexx
- Greece · Suvexx
- Hungary · Nomigrin
- Ireland · Migsun
- Italy · Sumanet
- Lithuania · Migsun
- Latvia · Migsun
- Netherlands · Suvexx
- Norway · Nomigrin
- Poland · Frimig Duo
- Portugal · Suvexx
- Sweden · Nomigrin
- Slovakia · Frimig Duo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b8da7172-e9cb-420b-b9b7-ef3a81215f27 GET /v1/drugs/b8da7172-e9cb-420b-b9b7-ef3a81215f27?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "85; 500",
"substance": "SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM",
"productndc": "47335-410",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "ANDA202803",
"marketing_category": "ANDA"
}See everything about sumatriptan and naproxen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.